Your browser doesn't support javascript.
loading
Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study.
Gunaldi, Meral; Duman, Berna Bozkurt; Afsar, Cigdem Usul; Paydas, Semra; Erkisi, Melek; Kara, I Oguz; Sahin, Berksoy.
Afiliação
  • Gunaldi M; Department of Medical Oncology, Bakirkoy Research and Training Hospital, Istanbul, Turkey meralgunaldi@gmail.com.
  • Duman BB; Department of Medical Oncology, Adana Research and Training Hospital, Istanbul, Turkey.
  • Afsar CU; Department of Medical Oncology, Cukurova University Medical School, Istanbul, Turkey.
  • Paydas S; Department of Medical Oncology, Cukurova University Medical School, Istanbul, Turkey.
  • Erkisi M; Department of Medical Oncology, Cukurova University Medical School, Istanbul, Turkey.
  • Kara IO; Department of Medical Oncology, Cukurova University Medical School, Istanbul, Turkey.
  • Sahin B; Department of Medical Oncology, Cukurova University Medical School, Istanbul, Turkey.
J Oncol Pharm Pract ; 22(2): 242-7, 2016 Apr.
Article em En | MEDLINE | ID: mdl-25567518

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Trastuzumab / Cardiopatias / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Trastuzumab / Cardiopatias / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Turquia